Send us a text

Today, the FDA met with a panel of experts to discuss testosterone replacement therapy, its risks, benefits and the future of access for millions of men. So we brought in the heavy hitters.

In this roundtable breakdown, Mike Belkin (Mens HealthSpan), Mason Collins (Live Oak Testosterone), Rick Collins (Defense Lawyer) and Josh Dull (Virtus Health Optimization) sit down with TRT DAD to cut through the noise and tell you what the FDA meeting really means for TRT clinics, patients and the entire men's health industry.

This is the episode everyone in the TRT community needs to hear. 

No fear mongering. No spin. Just real talk, real experts and real answers.

@TRTDAD on YouTube

@trt_talk on TikTok

@trt_dad on Instagram